B-CELL LYMPHOMA
Clinical trials for B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR cancer therapy trial halted: what happened with CTX110?
Disease control TerminatedThis study tested a one-time treatment using CRISPR-edited immune cells from a donor (CTX110) in 93 adults with B-cell cancers like lymphoma or leukemia that had come back or stopped responding to other treatments. The goal was to see if these cells were safe and could shrink tum…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Experimental CAR-T therapy targets tough lymphoma
Disease control TerminatedThis early-phase study tested a new treatment called ASP2802 for adults with CD20-positive B-cell lymphoma that returned or stopped responding to prior therapy. The treatment involves collecting a patient's own immune cells, modifying them to better fight cancer, and giving them …
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC